Bain Capital, a private investment firm, completed the acquisition of Fabbrica Italiana Sintetici, a developer and manufacturer of small molecule active pharmaceutical ingredients and intermediates, from Nine Trees Group, a small molecule company. Financial terms were not disclosed. “In over 60 years of history, the Ferrari Family has created, developed and continuously supported FIS – Fabbrica Italiana Sintetici, leading it to become the leader of the small molecule and active pharmaceutical ingredients sector in Italy, and one of the best-in-class developers and manufacturers in Europe and Globally. Today FIS is ideally positioned to further grow and expand internationally to become one of the world leaders in the APIs / small molecule industry," Giampaolo Ferrari, Alessandro Ferrari and Andrea Cappellato Ferrari, Chairman and Managing Directors of NTG and FIS.